Editas Medicine, Inc. (EDIT)

Editas Medicine Operating Expense Breakdown

Period Ending	Sep 29, 2024	Jun 29, 2024	Mar 31, 2024	Dec 31, 2023	Sep 29, 2023	Jun 29, 2023	Mar 30, 2023	Dec 31, 2022	Sep 29, 2022	Jun 29, 2022	Mar 30, 2022	Dec 31, 2021	Sep 29, 2021	Jun 29, 2021	Mar 30, 2021	Dec 31, 2020	Sep 29, 2020	Jun 29, 2020	Mar 30, 2020	Dec 31, 2019	Sep 29, 2019	Jun 29, 2019	Mar 31, 2019	Dec 31, 2018	Sep 29, 2018	Jun 29, 2018	Mar 30, 2018	Dec 31, 2017	Sep 29, 2017	Jun 29, 2017	Mar 30, 2017	Dec 31, 2016	Sep 29, 2016
Research and Development	220.19M	213.07M	188.63M	177.65M	160.09M	160.91M	174.79M	174.96M
Research and Development Growth	37.54%	32.41%	7.92%	1.54%	-0.26%	8.39%	26.16%	22.77%
General and Administrative	70.09M	66.99M	65.98M	69.65M	73.18M	74.43M	74.17M	70.70M
General and Administrative Growth	-4.23%	-10.00%	-11.03%	-1.49%	5.69%	7.57%	-0.16%	-7.19%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.